153 related articles for article (PubMed ID: 12768801)
1. [Youth health care: much prevention for little money].
Verloove-Vanhorick SP; Verkerk PH; van Leerdam FJ; Reijneveld SA; Hirasing RA
Ned Tijdschr Geneeskd; 2003 May; 147(19):895-8. PubMed ID: 12768801
[TBL] [Abstract][Full Text] [Related]
2. Is it feasible to pool funds for local children's services in England? Evidence from the national evaluation of children's trust pathfinders.
Lorgelly P; Bachmann M; Shreeve A; Reading R; Thorburn J; Mugford M; O'Brien M; Husbands C
J Health Serv Res Policy; 2009 Jan; 14(1):27-34. PubMed ID: 19103914
[TBL] [Abstract][Full Text] [Related]
3. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.
Welte R; van den Dobbelsteen G; Bos JM; de Melker H; van Alphen L; Spanjaard L; Rümke HC; Postma MJ
Vaccine; 2004 Dec; 23(4):470-9. PubMed ID: 15530695
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands].
van den Berg M; de Wit GA; Vijgen SM; Busch MC; Schuit AJ
Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1329-34. PubMed ID: 18661860
[TBL] [Abstract][Full Text] [Related]
6. Preventing or accelerating emergency care for children with complex healthcare needs.
Sutton D; Stanley P; Babl FE; Phillips F
Arch Dis Child; 2008 Jan; 93(1):17-22. PubMed ID: 18156477
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
Blake DR; Gaydos CA; Quinn TC
Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children.
Frick KD; Lietman TM; Holm SO; Jha HC; Chaudhary JS; Bhatta RC
Bull World Health Organ; 2001; 79(3):201-7. PubMed ID: 11285663
[TBL] [Abstract][Full Text] [Related]
9. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
[TBL] [Abstract][Full Text] [Related]
11. An activity-based cost analysis of the Honduras community-based, integrated child care (AIN-C) programme.
Fiedler JL; Villalobos CA; De Mattos AC
Health Policy Plan; 2008 Nov; 23(6):408-27. PubMed ID: 18755734
[TBL] [Abstract][Full Text] [Related]
12. The economics of prevention: does it save money?
Mirvis DM; Chang CF
Tenn Med; 2004 Nov; 97(11):495-6, 498. PubMed ID: 15620201
[No Abstract] [Full Text] [Related]
13. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
14. Meeting increased demand.
Blair A
Jpn Hosp; 2004 Jul; (23):19-22. PubMed ID: 19195249
[TBL] [Abstract][Full Text] [Related]
15. Cost of outpatient medical care for children and youth with special health care needs: investigating the impact of the medical home.
Damiano PC; Momany ET; Tyler MC; Penziner AJ; Lobas JG
Pediatrics; 2006 Oct; 118(4):e1187-94. PubMed ID: 17015507
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of a latrine revision programme in Kabul, Afghanistan.
Meddings DR; Ronald LA; Marion S; Pinera JF; Oppliger A
Bull World Health Organ; 2004 Apr; 82(4):281-9. PubMed ID: 15259257
[TBL] [Abstract][Full Text] [Related]
19. Youth health care in The Netherlands: a bird's eye view.
Verbrugge HP
Pediatrics; 1990 Dec; 86(6 Pt 2):1044-7. PubMed ID: 2243736
[TBL] [Abstract][Full Text] [Related]
20. Children in the Norwegian health care system.
Lie SO
Pediatrics; 1990 Dec; 86(6 Pt 2):1048-52. PubMed ID: 2243737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
